Gaudium IVF, a company in the Healthcare Service Provider industry, reported revenue of ₹37 crore and net profit of ₹9.41 crore for the September 2026 quarter.
Gaudium IVF (NSE: GAUDIUMIVF) closed at ₹99.57 on 20 Nov 2026. Its market capitalisation is ₹725 crore and it trades at 31.3 times earnings.
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.